Beyond Surveys: How to Leverage Patient Communities for Real-World Evidence

Traditional surveys offer a snapshot. Patient communities tell the full story.

In this webinar, discover how leading life sciences teams are going beyond standalone surveys to generate more robust, meaningful real-world evidence (RWE) by tapping into the power of patient communities.

The featured speakers will explore how medical affairs, health economics and outcomes research (HEOR) and RWE teams can use online health communities to:

• Uncover rich, unstructured data to complement claims and electronic health record (EHR) sources
• Conduct direct-to-patient research with high response rates and recontact capabilities
• Build virtual registries for longitudinal evidence generation
• Strengthen evidence packages with authentic patient-reported outcomes (PROs)

Register for this webinar to learn how patient communities are transforming the way pharma approaches evidence generation — empowering smarter decisions and more impactful outcomes.

Speakers

Richard Tsai, SVP Real-World Evidence, Inspire

Richard is a life sciences and digital health executive with more than 20 years of experience in marketing, product development and commercial strategy. In addition to overseeing Real-World Evidence, Richard is responsible for developing Inspire’s HealthJourney data and engagement platform, which empowers patients and caregivers across their medical journey and accelerates gathering of real-world insights of diseases or therapeutics for researchers. Prior to joining Inspire, he held positions at Thermo Fisher Scientific, Rare Genomics Institute and Hopkins Biotech Network. Richard completed his undergraduate degree at the University of California, Riverside, and a Master’s degree in Biotechnology, Business Enterprise and Regulatory Affairs from Johns Hopkins University.

Message Presenter

Bethany Kalich, Director, Digital Medicine, Amgen

Bethany Kalich is a healthcare innovator with expertise in cardiovascular care, patient health literacy and digital medicine. As Director of Digital Medicine at Amgen, she leads efforts to integrate technology, behavioral psychology and clinical evidence to empower patients and support clinicians. Her work centers on shared decision-making and patient activation science, driving strategies that improve outcomes by helping people better understand, engage with and act in their health.

Message Presenter